Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
TerminatedNCT06514742
Efficacy, Safety, and Tolerability of Aticaprant 10 mg for depression
This study was terminated in the United States, in Belgium, in Brazil, .... It is testing Efficacy, Safety, and Tolerability of Aticaprant 10 mg for depression.
Depression, AnhedoniaDrugFrom 18 Years to 64 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: June 26, 2024
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 101
- Sponsor
- Janssen Research & Development, LLC
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Belgium, Brazil, ...
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT06514742
- Official title
- A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and an Open Label Long-term Extension Treatment With Aticaprant
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Belgium · 4 sites
- AnimaAlkenSite status: Not listed — confirm with the team
- Chu TivoliLa LouvièreSite status: Not listed — confirm with the team
- Centre Hospitalier Specialise Notre Dame Des Anges AsblLiègeSite status: Not listed — confirm with the team
- MeclinasMechelenSite status: Not listed — confirm with the team
Brazil · 4 sites
- Universidade Federal do Ceara Hospital Universitario Walter CantidioFortalezaSite status: Not listed — confirm with the team
- NPCRS Nucleo de Pesquisa Clinica do Rio Grande do SulPorto AlegreSite status: Not listed — confirm with the team
- Centro Integrado FaciliSão Bernardo do CampoSite status: Not listed — confirm with the team
- BR TrialsSão PauloSite status: Not listed — confirm with the team
Bulgaria · 4 sites
- Mental Health Center Prof. Dr. Ivan TemkovBurgasSite status: Not listed — confirm with the team
- Medical Center Mentalcare OODPlovdivSite status: Not listed — confirm with the team
- MHC - Sofia, EOODSofiaSite status: Not listed — confirm with the team
- Centre for Mental Health Prof.N.Shipkovenski EOODSofiaSite status: Not listed — confirm with the team
Finland · 6 sites
- Terveystalo RuoholahtiHelsinkiSite status: Not listed — confirm with the team
- Savon PsykiatripalveluKuopioSite status: Not listed — confirm with the team
- Northern Clinical Trial CoordinatorsOuluSite status: Not listed — confirm with the team
- Oulu Mentalcare OyOuluSite status: Not listed — confirm with the team
- Mehilainen FinlaysonTampereSite status: Not listed — confirm with the team
- Clinical Research Services Turku - CRSTTurkuSite status: Not listed — confirm with the team
Hungary · 9 sites
- Semmelweis EgyetemBudapestSite status: Not listed — confirm with the team
- Eszak Budai Szent Janos CentrumkorhazBudapestSite status: Not listed — confirm with the team
- Processus KftBudapestSite status: Not listed — confirm with the team
- Bugat Pal KorhazGyöngyösSite status: Not listed — confirm with the team
- Gyor Moson Sopron Varmegyei Petz Aladar Egyetemi Oktato KorhazGyőrSite status: Not listed — confirm with the team
- Dr Mathe es Tarsa BtKalocsaSite status: Not listed — confirm with the team
- Pte Aok Pszichiatriai KlinikaPécsSite status: Not listed — confirm with the team
- PsychoTech KftPécsSite status: Not listed — confirm with the team
- Tolna Varmegyei Balassa Janos KorhazSzekszárdSite status: Not listed — confirm with the team
Poland · 5 sites
- Osrodek Badan Klinicznych CLINSANTE S C Ewa Galczak Nowak Malgorzata TrzaskaBydgoszczSite status: Not listed — confirm with the team
- Centrum Zdrowia AlceaGdanskSite status: Not listed — confirm with the team
- Centrum Badan Klinicznych PI House sp z o oGdanskSite status: Not listed — confirm with the team
- Osrodek Badan Klinicznych CLINSANTE S CTorunSite status: Not listed — confirm with the team
- Ginemedica Sp. z o.o.WroclawSite status: Not listed — confirm with the team
Spain · 8 sites
- Hosp. de La Santa Creu I Sant PauBarcelonaSite status: Not listed — confirm with the team
- Institucion Hosp Hestia PalauBarcelonaSite status: Not listed — confirm with the team
- Hospital Ramon y CajalMadridSite status: Not listed — confirm with the team
- Centro Salud Mental La CorredoriaOviedoSite status: Not listed — confirm with the team
- Corporacio Sanitari Parc TauliSabadellSite status: Not listed — confirm with the team
- Hosp. Virgen Del RocioSevilleSite status: Not listed — confirm with the team
- Hosp. Alvaro CunqueiroVigoSite status: Not listed — confirm with the team
- Hosp. Prov. de ZamoraZamoraSite status: Not listed — confirm with the team
Sweden · 5 sites
- Affecta PskyiatrimottagningHalmstadSite status: Not listed — confirm with the team
- Linkoping University HospitalLinköpingSite status: Not listed — confirm with the team
- ProbarE i Lund ABLundSite status: Not listed — confirm with the team
- ProbarE i Stockholm ABStockholmSite status: Not listed — confirm with the team
- Studieenheten Akademiskt Specialistcentrum StockholmStockholmSite status: Not listed — confirm with the team
United States · 39 sites
- UAB Huntsville Regional Medical CampusHuntsville, AlabamaSite status: Not listed — confirm with the team
- IMA Clinical Research PCPhoenix, ArizonaSite status: Not listed — confirm with the team
- Noble Clinical ResearchTucson, ArizonaSite status: Not listed — confirm with the team
- Advanced Research Center IncAnaheim, CaliforniaSite status: Not listed — confirm with the team
- CI TrialsBellflower, CaliforniaSite status: Not listed — confirm with the team
- Behavioral Research Specialists LLCGlendale, CaliforniaSite status: Not listed — confirm with the team
- Sun Valley Research CenterImperial, CaliforniaSite status: Not listed — confirm with the team
- ATP Clinical ResearchOrange, CaliforniaSite status: Not listed — confirm with the team
- Lumos Clinical Research Center LLCSan Jose, CaliforniaSite status: Not listed — confirm with the team
- Viking Clinical Research LtdTemecula, CaliforniaSite status: Not listed — confirm with the team
- Sunwise Clinical ResearchWalnut Creek, CaliforniaSite status: Not listed — confirm with the team
- MCB Clinical Research Centers LLCColorado Springs, ColoradoSite status: Not listed — confirm with the team
- Humanity Clinical Research CorpAventura, FloridaSite status: Not listed — confirm with the team
- Elligo Independent Research Sites Mindful Behavioral HealthBoca Raton, FloridaSite status: Not listed — confirm with the team
- Gulfcoast Medical Research CenterFort Myers, FloridaSite status: Not listed — confirm with the team
- New Life Medical Research Center, Inc.Hialeah, FloridaSite status: Not listed — confirm with the team
- LCC Medical Research Institute IncMiami, FloridaSite status: Not listed — confirm with the team
- Floridian Clinical Research LLCMiami, FloridaSite status: Not listed — confirm with the team
- Medquest Translational SciencesMiami Lakes, FloridaSite status: Not listed — confirm with the team
- Best Choice Medical and Research ServicePembroke Pines, FloridaSite status: Not listed — confirm with the team
- K2 Medical ResearchTampa, FloridaSite status: Not listed — confirm with the team
- Neuroscience Research InstituteWest Palm Beach, FloridaSite status: Not listed — confirm with the team
- Accelerated Clinical Trials LLCPeachtree Corners, GeorgiaSite status: Not listed — confirm with the team
- Southern Illinois University School of MedicineSpringfield, IllinoisSite status: Not listed — confirm with the team
- DelRicht ResearchNew Orleans, LouisianaSite status: Not listed — confirm with the team
- CBH HealthGaithersburg, MarylandSite status: Not listed — confirm with the team
- Integrative Clinical Trials LLCBrooklyn, New YorkSite status: Not listed — confirm with the team
- Fieve Clinical Research IncNew York, New YorkSite status: Not listed — confirm with the team
- New Hope Clinical ResearchCharlotte, North CarolinaSite status: Not listed — confirm with the team
- Patient Priority Clinical Sites LLCCincinnati, OhioSite status: Not listed — confirm with the team
- OSU Department of Psychiatry and Behavioral HealthColumbus, OhioSite status: Not listed — confirm with the team
- Conrad Clinical ResearchEdmond, OklahomaSite status: Not listed — confirm with the team
- Suburban Research AssociatesMedia, PennsylvaniaSite status: Not listed — confirm with the team
- UTHealth Houston Center for Interventional PsychiatryHouston, TexasSite status: Not listed — confirm with the team
- Brain Health ConsultantsHouston, TexasSite status: Not listed — confirm with the team
- Red Oak Psychiatry AssociatesHouston, TexasSite status: Not listed — confirm with the team
- Revival Research Institute LLCMcKinney, TexasSite status: Not listed — confirm with the team
- Perceptive Pharma ResearchRichmond, TexasSite status: Not listed — confirm with the team
- Northwest Clinical Research CenterBellevue, WashingtonSite status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT06514742. We help you review the study, but cannot decide medical eligibility.
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Aticaprant, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with depression; age range: From 18 Years to 64 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Janssen Research & Development, LLC, which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
TerminatedNCT02389712
16-week Comparative Effectiveness study of Lamotrigine vs. Fluoxetine for Depression in bipolarity
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
TerminatedEUCTR 2010-022744-21
A 12-week, proof of concept prospective, randomized, double blind, phase 2a study to compare safety and efficacy of masitinib to placebo in the treatment of mood disorders in patients with antidepr...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
TerminatedNCT05169710
Investigational Drug for depression
This study was terminated in the United States, in Canada, in Bulgaria, .... It is testing investigational Drug for depression.